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 The genetically modified organisms (GMOs) global policy 
landscape shows one of divergence not convergence. The United 
States stands on one side as strong advocates for GMOs through 
approval and production, while the European Union, on the other 
side, applies the precautionary principle to GMOs as they appear 
to be more cautious with GMO production. Due to this 
polarization, other countries are able to more easily develop their 
own unique policies, mostly falling somewhere in between the 
leniency towards approval of the United States and the rigidity 
towards approval of the European Union. In the realm of GMO 
policy, we are not seeing the normal trend of convergence around 
a similar policy or idea frame; instead, there are observable 
differences among countries’ policies (Prakash 2003). This brief 
discusses which countries are approving GMOs and identifies 
some possible indicators that would suggest their willingness to 
approve GM crops, as well as the policies surrounding GMO 
regulation. However, it is important to note that approval and 
production of GMOs are two very different aspects of the industry. 
While the data covers over forty individual countries across the 
globe, a special emphasis has been placed on the United States, 
China, Japan, Mexico, and the European Union as these are key 
trade countries for the United States, as well as leaders in the 
realm of either GMO research or policy.  
 
The United States regulates GMOs under three main 
agencies: United States Department of Agriculture (USDA), 
United States Environmental Protection Agency (EPA), and 
United States Food and Drug Administration (FDA). The EPA 
regulates plants that are genetically engineered to carry a gene 
with a pesticide (such as Bt) and genetically engineered microbial 
pesticides; the USDA regulates transgenic plants and the FDA 
regulates the safety of GMOs that are eaten by animals and 
humans. The United States is a strong supporter of GMO 
development and cultivation, as is evident by being a world leader 
in GM plant cultivation.1. However, the United States signed into 
a law a GMO labeling bill in 2016 that will take effect within the 
next two years. Although the United States is not the number one 
leader in the total number of GMO varieties approved, it has still 
approved192 varieties and falls second to the number approved 
to Japan.2 
 
China has a long history of failures and success in 
agricultural production. During the Great Leap Forward, a large 
number of people died of starvation due to decreased production; 
however, when Deng Xiaoping took over the agricultural sector, 
the country returned to its focus on agricultural production.3 
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However, it was not until 1997 that China began to 
issue certificates to cultivate GMOs.4 China’s 
Ministry of Agriculture and the Biosafety Committee 
set regulations, award certificates, and control the 
biosafety management of GMOs within China. The 
classifications of GMOs are based upon 
safeguarding the health of humans, animals, plants, 
and microorganisms. In addition to protecting live 
organisms, general protection of the environment is 
also a specific goal of GMO classification in China. 
5 The United States has a long history of GMO trade 
with China and China currently the largest importer 
of United States soybeans; however, there have 
been complications within the trade system.6 For 
instance, China has blocked corn shipments from 
docking due to contamination of non-approved 
GMOs. Although other countries scrutinize imports 
closely, China has caused massive disruption in the 
industry with their rejection of corn shipments. In 
contrast to the 192 varieties of GMOs approved in 
the United States, a total of 60 GMOs have been 
approved in China, 17 of which are corn varieties 
and 10 of which are soybean varieties.4 
 
Japan enacted the Cartagena Act in 2003 to 
implement the Cartagena Protocol on Biosafety and 
uses this as the primary regulatory protocols for 
GMOs.7  The Cartagena Protocol aims to ensure the 
safe handling, transport, and use of living modified 
organisms resulting from modern biotechnology that 
may have adverse effects. Although it is technically 
legal to plant GM crops, only ornamental flowers are 
commercially planted. However, Japan is one of the 
largest importers of GMO foods and grains.7 Public 
disapproval is the main reason for the lack of 
commercially planted GMOs.7 Despite the public 
perception of GMOs, Japan has the largest number 
of GMO varieties approved (221), of the approved 
varieties 17 are corn and 23 are soybean.8 
 
Mexico is also global leader in the 
development of GMOs. The Mexican Department of 
Health is the main body for regulation, approval, and 
enforcement. Mexico has also adopted the 
Cartagena Protocol as its guideline for GMO 
regulations.8 Although some cultural concerns 
(tortilla production and quality) have been raised 
about GMO corn, including a complete ban on GMO 
production for a period of time, cultivation has 
resumed and is the majority of corn/soy planted. 
The farmers’ focus is quality and quantity, not 
genetic makeup. Mexico is ranked second in corn 
and soybean imports from the United States.9 The 
country has approved 158 GMO varieties, 68 of 
which being corn and 22 of which being soybeans.10 
 
The European Union (EU) places strict 
regulation on GMOs. The regulations include an 
extensive authorization process, as well as allowing 
for member states to opt for even stricter regulations 
within their own territories. The European Union’s 
policy is based on the precautionary principle, a risk-
averse stance towards biotechnology. GMOs within 
the European Union are assigned a unique identifier 
and are labeled.11 The primary body for 
authorization is the European Food and Safety 
Administration, but governments within each 
country must also approve it. To cultivate GM crops, 
the process begins within a member state and then 
works up to approval from the European Union; 
however, once approval is obtained from the EU, 
individuals member states can still choose opt out 
and restrict production. While the EU is the main 
overseer of GMO regulation, it is at the discretion of 
each member state to enforce the policy. Spain is 
the leader in GMO cultivation within the EU, while 
several other countries ban cultivation, but do allow 
imports.12 The European union has approved 88 
varieties of GMOs, 41 being corn varieties, and 15 
being soybean varieties.12 
 
Although the United States is seen as one 
extreme for GMO approval, Japan leads the world 
in number of GMOs approved. While one might 
assume that the difficulty in gaining approval would 
coexist with the number of GMOs approved per 
country, the research shows that this is not 
necessarily the case (see figure 2). For instance, 
many who have signed the Cartagena protocol have 
far more GMOs approved than those with weaker 
approval processes. Even more interesting is that 
the approval number does not necessarily 
correspond to the number of GMO acres planted. 
Although the EU has approved 100 GMOs, a 
leading number in the world, not many member-
states produce any GM crops at all. In some 
countries in the European Union, like Germany, 
GMO production is banned all together. Japan is 
leading the world with approved GMO varieties 
despite signing the Cartagena Protocol and having 
a moderately strict approval process but they also 
are not one of the top 28 biotech producing 
countries. 




Rating of Difficulty to Gain Approval: 
1-Scientific based, relatively efficient and quick process 
(US approach). 
2- Scientific based, but signed Cartagena Protocol for 
Biodiversity. 
3-Precautionary approach, long and stringent process 
(EU approach). 
 
The strongest indicator of if a country will 
approve and produce a GMO product is by region 
(referenced in figure 2). There is a noticeable 
correlation between region and GMO approval. For 
instance, North America leads in average number 
approved, followed by Central America, Oceana, 
Asia, and South Africa. The figure shows the 
substantial difference between North American, 
Asian, and European regions in approving GMOs. 
 
There are many different policies 
surrounding GMOs. They vary greatly and do not 
appear to be converging. Policies, especially those 
surrounding international trade, often begin to 
converge around leading countries. This is not the 




Data Collected from: ISAAA’S GM Approval Database. (N.d.) 
International Service for the Acquisition of Agri-Biotech 
Applications. http://www.isaaa.org/gmapprovaldatabase/. 
 
The existing regulatory polarization between 
US and EU biotechnology approaches has not 
forced a convergence around either of these two 
international models.14 Rather, the polarization 
among two leading nations have appeared to cause 
diversity in world-wide GMO policy instead of 
convergence or following one of the two binary 
approaches. With this polarization of two world 
centers, countries are more easily able to develop 
unique policies that diverge from one side and lie 
between the two approaches. Many different factors 
were researched to find patterns of the type of 
policies formed and number of approved varieties in 
a country. Neither type of government regime nor 
the GDP (nominal, or PPP) appear to be correlated 
with adoption of strict or lenient policies toward 
GMO approval and cultivation. The most correlated 
factor found was the region (although there were 
some outliers). The reason for stringent policies 
cited by some governments, specifically the 
European Union and local Chinese governments, 
was public fear or concern, despite scientific 
evidence.14  
 
For companies, the research suggests that 
increased lobbying is necessary to gain access into 
international markets, but that additional 
campaigning to convince farmers to cultivate GMO 
products is also necessary. The research shows 
targeted regions where lack of approval is common; 
a biotech company may wish to allocate its 
resources to gain use and approval of one specific 
country. Starting with one country in a region where 
approval is difficult would allow the producer to build 













































































































support as a factor for GMO limits, slow integration 
could ultimately help expansion to the rest of the 
region. Further, this research shows markets in 
specific regions that non-GMO producers and 
exporters could target. 
 
 In this global world of policy divergence 
regarding GMOs, there are some policy solutions 
that would make trade easier to facilitate, while still 
allowing countries to maintain their divergent 
policies. One would be a central database updated 
at the beginning of each year regarding what GMO 
varieties countries would accept for the upcoming 
harvest. Another solution could be requiring seed 
distributors to inform farmers, which countries do 
not accept the GMO variety they are selling. 
Increasing transparency from both governmental 
and industry standpoints would allow the farmers, 
as well as elevators, to make more informed 
decisions when choosing what varieties to plant or 
accept. It is important to recognize that the field of 
GMOs, in regards to technology, policies, and use, 
is continually changing. The best producers, 
exporters, and companies must stay on top of these 
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